Oak Pharma
ActiveSummary
Oak Pharma has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €78,004 and a net result of €48,250. Equity is growing by ~8.2% per year across the filed fiscal years. Its solvency ranks better than 23% of 8160 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability82▲+13
Solvency42▲+13
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,000 at 30 days acceptable
Liquidity tight (current ratio 1.01 against 0.8 in 2024; short-term debt: 82.6% and cash: 2.8% of total assets), and 83.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
16.7%
Return on assets
10.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 8160 sector peers (2025).
NBB · sector comparisonPosition among 8160 sector peers
Solvency
better than 23%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
29 d early
2024
21 d early
2023
12 d early
2022
4 d early
2021
11 d early
2020
2 d early
2019
3 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 11 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€78,004▲ 162%
2024 · €29,754
Total assets
€468,141▼ 38.0%
2024 · €754,998
Net result
€48,250▲ 1,022%
2024 · €4,299
Working capital
€3,162
2024 · -€143,859
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€7,532-€50,891€69,414€12,675▼ 81.7%€71,415▲ 463%
Net result€3,537below the sector's middle half▲ 13,317%-€55,588below the sector's middle half€56,274within the sector's middle half€4,299within the sector's middle half▼ 92.4%€48,250within the sector's middle half▲ 1,022%
Equity€23,129below the sector's middle half▲ 18.1%-€30,819below the sector's middle half€25,455below the sector's middle half€29,754below the sector's middle half▲ 16.9%€78,004below the sector's middle half▲ 162%
Total assets€196,041below the sector's middle half▲ 855%€820,514within the sector's middle half▲ 319%€811,291within the sector's middle half▼ 1.1%€754,998within the sector's middle half▼ 6.9%€468,141within the sector's middle half▼ 38.0%
Debt€172,912▲ 18,375%€851,333▲ 392%€785,835▼ 7.7%€725,244▼ 7.7%€390,137▼ 46.2%
Working capital-€49,176below the sector's middle half-€257,126below the sector's middle half▼ 423%-€189,467below the sector's middle half▲ 26.3%-€143,859below the sector's middle half▲ 24.1%€3,162below the sector's middle half
Solvency11.8%below the sector's middle half▼ 83.6pp-3.8%below the sector's middle half▼ 15.6pp3.1%below the sector's middle half▲ 6.9pp3.9%below the sector's middle half▲ 0.8pp16.7%below the sector's middle half▲ 12.7pp
Current ratio0.72below the sector's middle half▼ 21.220.70below the sector's middle half▼ 0.020.76below the sector's middle half▲ 0.060.80below the sector's middle half▲ 0.041.01below the sector's middle half▲ 0.21
Return on assets (ROA)1.8%within the sector's middle half▲ 1.7pp-6.8%below the sector's middle half▼ 8.6pp6.9%within the sector's middle half▲ 13.7pp0.6%within the sector's middle half▼ 6.4pp10.3%within the sector's middle half▲ 9.7pp
Staff (FTE)0.4below the sector's middle half0.4below the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 463% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €468,141
Fixed assets
€78,494 ▼ 55.9%
Current assets
€389,647 ▼ 32.5%
Equity and liabilities €468,141
Equity
€78,004 ▲ 162%
Debt
€390,137 ▼ 46.2%
Debt's share of the balance-sheet total falls from 96.1% to 83.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€100,319▲
2024 · €77,414
Cash flow
€77,154▲
2024 · €69,038
Quick ratio
0.51▲
2024 · 0.31
Debt to equity
5.00▼
2024 · 24.37
ROE
61.9%▲
2024 · 14.4%
Interest coverage
15.40▲
2024 · 11.86
Debt ≤ 1 year
€386,485▼
2024 · €720,866
Income taxes
€16,652▲
2024 · €1,848
Staff costs
-€363▼
2024 · €53
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 2,605 companies that looked in July 2024 the way this one looks now, 1.0% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.0%
went bankrupt
2.0%
stopped otherwise
97%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,605 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €29,827 | €46,374 | -€39 | €53 | -€363 | ▼ 782% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,990 | €41,264 | €87,182 | €64,739 | €28,904 | ▼ 55.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €81,569 | €71,833 | ▼ 11.9% |
| Other operating charges640/8 | €991 | €1,570 | €1,165 | €806 | €588 | ▼ 27.1% |
| Non-recurring operating charges66A | - | - | - | - | €90,617 | - |
| Gross operating margin9900 | €41,340 | €38,316 | €157,723 | €159,842 | €262,993 | ▲ 64.5% |
| Operating profit (loss)9901 | €7,532 | -€50,891 | €69,414 | €12,675 | €71,415 | ▲ 463% |
| Financial income75/76B | - | €0 | €8 | €2 | - | - |
| Recurring financial income75 | - | €0 | €8 | €2 | - | - |
| Financial charges65/66B | €1,863 | €4,514 | €10,045 | €6,530 | €6,513 | ▼ 0.2% |
| Recurring financial charges65 | €1,863 | €4,514 | €10,045 | €6,530 | €6,513 | ▼ 0.2% |
| Profit (loss) for the period before taxes9903 | €5,669 | -€55,405 | €59,377 | €6,147 | €64,902 | ▲ 956% |
| Income taxes67/77 | €2,132 | €183 | €3,103 | €1,848 | €16,652 | ▲ 801% |
| Profit (loss) for the period9904 | €3,537 | -€55,588 | €56,274 | €4,299 | €48,250 | ▲ 1,022% |
| Profit (loss) for the period to be appropriated9905 | €3,537 | -€55,588 | €56,274 | €4,299 | €48,250 | ▲ 1,022% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €196,041 | €820,514 | €811,291 | €754,998 | €468,141 | ▼ 38.0% |
| Fixed assets21/28 | €72,305 | €228,498 | €223,195 | €177,992 | €78,494 | ▼ 55.9% |
| Intangible fixed assets21 | €71,377 | €227,949 | €223,024 | €177,992 | €78,250 | ▼ 56.0% |
| Tangible fixed assets22/27 | €928 | €549 | €171 | - | €197 | - |
| Plant, machinery and equipment23 | - | - | - | - | €197 | - |
| Furniture and vehicles24 | €928 | €549 | €171 | - | - | - |
| Financial fixed assets28 | - | - | - | - | €48 | - |
| Current assets29/58 | €123,736 | €592,016 | €588,095 | €577,007 | €389,647 | ▼ 32.5% |
| Stocks and contracts in progress3 | - | €466,809 | €351,605 | €352,170 | €192,260 | ▼ 45.4% |
| Stocks30/36 | - | €466,809 | €351,605 | €352,170 | €192,260 | ▼ 45.4% |
| Amounts receivable within one year40/41 | €73,443 | €94,727 | €208,759 | €156,888 | €181,007 | ▲ 15.4% |
| Trade receivables40 | €51,057 | €94,727 | €196,180 | €132,842 | €181,007 | ▲ 36.3% |
| Other amounts receivable41 | €22,386 | - | €12,579 | €24,046 | - | - |
| Current investments50/53 | - | €2,726 | - | - | - | - |
| Cash at bank and in hand54/58 | €47,082 | €9,606 | €23,697 | €64,766 | €12,897 | ▼ 80.1% |
| Deferred charges and accrued income490/1 | €3,211 | €18,148 | €4,034 | €3,183 | €3,482 | ▲ 9.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €196,041 | €820,514 | €811,291 | €754,998 | €468,141 | ▼ 38.0% |
| Equity10/15 | €23,129 | -€30,819 | €25,455 | €29,754 | €78,004 | ▲ 162% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €4,529 | €6,169 | €6,855 | €11,154 | €59,404 | ▲ 433% |
| Distributable reserves133 | €4,529 | €6,169 | €6,855 | €11,154 | €59,404 | ▲ 433% |
| Profit (loss) carried forward14 | - | -€55,588 | - | - | - | - |
| Amounts payable17/49 | €172,912 | €851,333 | €785,835 | €725,244 | €390,137 | ▼ 46.2% |
| Amounts payable within one year42/48 | €172,912 | €849,142 | €777,562 | €720,866 | €386,485 | ▼ 46.4% |
| Financial debts43 | €50,000 | €100,000 | €37,271 | €75,000 | €65,218 | ▼ 13.0% |
| Credit institutions430/8 | €50,000 | €100,000 | €37,271 | €75,000 | €50,000 | ▼ 33.3% |
| Other loans439 | - | - | - | - | €15,218 | - |
| Trade debts44 | €103,770 | €92,362 | €236,278 | €232,004 | €99,175 | ▼ 57.3% |
| Suppliers440/4 | €103,770 | €92,362 | €236,278 | €232,004 | €99,175 | ▼ 57.3% |
| Taxes, remuneration and social security45 | €2,142 | €2,913 | - | €1,848 | €2,092 | ▲ 13.2% |
| Taxes450/3 | €2,142 | €2,913 | - | €1,848 | €2,092 | ▲ 13.2% |
| Other amounts payable47/48 | €17,000 | €653,867 | €504,014 | €412,014 | €220,000 | ▼ 46.6% |
| Accrued charges and deferred income492/3 | - | €2,191 | €8,273 | €4,378 | €3,652 | ▼ 16.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €3,537 | -€55,588 | €56,274 | €4,299 | €48,250 | ▲ 1,022% |
| + Depreciation and write-downs630 | €2,990 | €41,264 | €87,182 | €64,739 | €28,904 | ▼ 55.4% |
| Operating cash flow (approximation) | €6,527 | -€14,324 | €143,456 | €69,038 | €77,154 | ▲ 11.8% |
| Investment in fixed assets (approximation) | - | -€197,457 | -€81,879 | -€19,536 | €70,593 | ▲ 461% |
| Change in cash | - | -€37,477 | €14,091 | €41,070 | -€51,869 | ▼ 226% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
19-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Back to profitnet €56,274
Net result €56,274 after one loss-making year.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet -€55,588
Net result drops to -€55,588, the lowest in the series; recovery starts the following year.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
03-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 3 days late
2019
09-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
25-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Oostkamp · 1 establishment unit since 2016
Ground area
5,327 m²
Building footprint
3,189 m²
Volume, LiDAR
17,473 m³
Parcel 31022I0613/00H000, Flanders · tallest building 10.1 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Oak Pharma BV
since 20162.257.918.488
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31022I0613/00H000 | Flanders | 5,327 m² | 1 · 3,189 m² | 10.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2023 · 2 entries · 9,128 EUR awarded · 9,128 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 4,928 EUR | 4,928 EUR |
| 2022 | 1 | 4,200 EUR | 4,200 EUR |
Recognitions · licences · registrations
Food safety, FASFC
1 siteOostkamp2.257.918.488
Similar companies · same sector, comparable size
SERCOLAB
BE 0431.052.360
Antwerpen · Eq €77,663
GESPODO LAB
BE 1026.184.477
Enghien · Eq €77,253
KUULO
BE 0554.698.953
Heist-op-den-Berg · Eq €79,161
MARK SCHNEIDER
BE 0675.754.557
Etterbeek · Eq €75,956
MEDAX
BE 0888.755.867
Kortrijk · Eq €75,621
Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 567 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded30-05-2016
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
64210Activities of holding companies
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0655792749
Registered
29-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.